---
reference_id: "PMID:38815595"
title: "Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study."
authors:
- Jensen TO
- Murray TA
- Grandits GA
- Jain MK
- Grund B
- Shaw-Saliba K
- Matthay MA
- Abassi M
- Ardelt M
- Baker JV
- Chen P
- Dewar RL
- Goodman AL
- Hatlen TJ
- Highbarger HC
- Holodniy M
- Lallemand P
- Laverdure S
- Leshnower BG
- Looney D
- Moschopoulos CD
- Mugerwa H
- Murray DD
- Mylonakis E
- Nagy-Agren S
- Rehman MT
- Rupert A
- Stevens R
- Turville S
- Weintrob A
- Wick K
- Lundgren J
- Ko ER
- ACTIV-3/TICO Study Group
journal: Lancet Microbe
year: '2024'
doi: 10.1016/S2666-5247(24)00015-6
content_type: abstract_only
---

# Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study.
**Authors:** Jensen TO, Murray TA, Grandits GA, Jain MK, Grund B, Shaw-Saliba K, Matthay MA, Abassi M, Ardelt M, Baker JV, Chen P, Dewar RL, Goodman AL, Hatlen TJ, Highbarger HC, Holodniy M, Lallemand P, Laverdure S, Leshnower BG, Looney D, Moschopoulos CD, Mugerwa H, Murray DD, Mylonakis E, Nagy-Agren S, Rehman MT, Rupert A, Stevens R, Turville S, Weintrob A, Wick K, Lundgren J, Ko ER, ACTIV-3/TICO Study Group
**Journal:** Lancet Microbe (2024)
**DOI:** [10.1016/S2666-5247(24)00015-6](https://doi.org/10.1016/S2666-5247(24)00015-6)

## Content

1. Lancet Microbe. 2024 Jun;5(6):e559-e569. doi: 10.1016/S2666-5247(24)00015-6. 
Epub 2024 May 27.

Early trajectories of virological and immunological biomarkers and clinical 
outcomes in patients admitted to hospital for COVID-19: an international, 
prospective cohort study.

Jensen TO(1), Murray TA(2), Grandits GA(2), Jain MK(3), Grund B(4), Shaw-Saliba 
K(5), Matthay MA(6), Abassi M(7), Ardelt M(6), Baker JV(8), Chen P(9), Dewar 
RL(10), Goodman AL(11), Hatlen TJ(12), Highbarger HC(10), Holodniy M(13), 
Lallemand P(10), Laverdure S(14), Leshnower BG(15), Looney D(16), Moschopoulos 
CD(17), Mugerwa H(18), Murray DD(19), Mylonakis E(20), Nagy-Agren S(21), Rehman 
MT(10), Rupert A(10), Stevens R(10), Turville S(22), Weintrob A(23), Wick K(24), 
Lundgren J(19), Ko ER(25); ACTIV-3/TICO Study Group.

Collaborators: Sahner D, Tierney J, Vogel SE, Herpin BR, Smolskis MC, McKay LA, 
Cahill K, Crew P, Sardana R, Raim SS, Hensely L, Lorenzo J, Mock R, Zuckerman J, 
Atri N, Miller M, Vallee D, Chung L, Kang N, Barrett K, Adam SJ, Read S, 
Draghia-Akli R, Currier J, Hughes E, Harrigan RH, Amos L, Carlsen A, Carter A, 
Collins G, Davis B, Denning E, DuChene A, Eckroth K, Engen N, Frase A, Gandits 
G, Grund B, Harrison M, Hurlbut N, Kaiser P, Koopmeiners J, Larson G, Meger S, 
Mistry SS, Murray T, Nelson R, Quan K, Quan SF, Reilly C, Siegel L, Thompson G, 
Vock D, Walski J, Gelijns AC, Moskowitz AJ, Bagiella E, Moquete E, O'Sullivan K, 
Marks ME, Accardi E, Kinzel E, Burris S, Bedoya G, Gupta L, Overbey JR, Santos 
M, Gillinov MA, Miller MA, Taddei-Peters WC, Fenton K, Sandkovsky U, Gottlieb 
RL, Mack M, Berhe M, Haley C, Dishner E, Bettacchi C, Golden K, Duhaime E, Ryan 
M, Burris S, Tallmadge C, Estrada L, Jones F, Villa S, Wang S, Robert R, Coleman 
T, Clariday L, Baker R, Hurutado-Rodriguez M, Iram N, Fresnedo M, Davis A, 
Leonard K, Ramierez N, Thammavong J, Duque K, Turner E, Fisher T, Robinson D, 
Ransom D, Maldonado N, Lusk E, Killian A, Palacious A, Solis E, Jerrow J, Watts 
M, Whitacre H, Cothran E, Smith PK, Barkauskas CE, Vekstein AM, Ko ER, Dreyer 
GR, Stafford N, Brooks M, Der T, Witte M, Gamarallage R, Franzone J, Ivey N, 
Lumsden RH, Mosaly N, Mourad A, Holland TL, Motta M, Lane K, McGowan LM, Stout 
J, Aloor H, Bragg KM, Toledo B, McLendon-Arvik B, Bussadori B, Hollister BA, 
Griffin M, Giangiacomo DM, Rodriguez V, Bokhart G, Eichman SM, Parrino PE, 
Spindel S, Bansal A, Baumgarten K, Hand J, Vonderhaar D, Nossaman B, Sylvia 
Laudun, Ames D, Broussard S, Hernandez N, Isaac G, Dinh H, Zheng Y, Tran S, 
McDaniel H, Crovetto N, Perin E, Costello B, Manian P, Sohail MR, Postalian A, 
Hinsu P, Watson C, Chen J, Fink M, Sturgis L, Walker K, Mahon K, Parenti J, 
Kappenman C, Knight A, Sturek JM, Barros A, Enfield KB, Kadl A, Green CJ, Simon 
RM, Fox A, Thornton K, Adams A, Badhwar V, Sharma S, Peppers B, McCarthy P, 
Krupica T, Sarwari A, Reece R, Fornaresico L, Glaze C, Evans R, Di F, Carlson S, 
Aucremanne T, Tennant C, Sutton LG, Buterbaugh S, Williams R, Bunner R, Traverse 
JH, Rhame F, Huelster J, Kethireddy R, Davies I, Salamanca J, Majeski C, Skelton 
P, Zarambo M, Sarafolean A, Bowdish ME, Borok Z, Wald-Dickler N, Hutcheon D, 
Towfighi A, Lee M, Lewis MR, Spellberg B, Sher L, Sharma A, Olds AP, Justino C, 
Loxano E, Romero C, Leong J, Rodina V, Quesada C, Hamilton L, Escobar J, 
Leshnower B, Bender W, Sharifpour M, Miller J, Farrington W, Baio KT, McBride M, 
Fielding M, Mathewson S, Porte K, Maton M, Ponder C, Haley E, Spainhour C, 
Rogers S, Tyler D, Madathil RJ, Rabin J, Levine A, Saharia K, Tabatabai A, Lau 
C, Gammie JS, Peguero ML, McKernan K, Audette M, Fleischmann E, Akbari K, Lee M, 
Chi A, Salehi H, Pariser A, Nyguyen PT, Moore J, Gee A, Vincent S, Zuckerman RA, 
Iribarne A, Metzler S, Shipman S, Johnson H, Newton C, Parr D, Miller L, Schelle 
B, McLean S, Rothbaum HR, Alvarez MS, Kalan SP, Germann HH, Hendershot J, 
Moroney K, Herring K, Cook S, Paul P, Walker-Ignasiak R, North C, Oldmixon C, 
Ringwood N, Muzikansky A, Morse R, Fitzgerald L, Morin HD, Brower RG, Reineck 
LA, Bienstock K, Steingrub JH, Hou PK, Steingrub JS, Tidswell MA, Kozikowski LA, 
Kardos C, DeSouza L, Romain S, Thornton-Thompson S, Talmor D, Shapiro N, 
Andromidas K, Banner-Goodspeed V, Bolstad M, Boyle KL, Cabrera P, deVilla A, 
Ellis JC, Grafals A, Hayes S, Higgins C, Kurt L, Kurtzman N, Redman K, Rosseto 
E, Scaffidi D, Shapiro N, Filbin MR, Hibbert KA, Parry B, Margolin J, Hillis B, 
Hamer R, Brait K, Beakes C, McKaig B, Kugener E, Jones AE, Galbraith J, Nandi U, 
Peacock R, Hendey G, Kangelaris K, Ashktorab K, Gropper R, Agrawal A, Yee KJ, 
Jauregui AE, Zhuo H, Almasri E, Fayed M, Hubel KA, Hughes AR, Garcia RL, Lim GW, 
Chang SY, Hendey G, Lin MY, Vargas J, Sihota H, Beutler R, Agarwal T, Wilson JG, 
Vojnik R, Perez C, McDowell JH, Roque J, Wang H, Huebinger RM, Patel B, Vidales 
E, Albertson T, Hardy E, Harper R, Moss MA, Baduashvili A, Chauhan L, Douin DJ, 
Martinez F, Finck LL, Bastman J, Howell M, Higgins C, McKeehan J, Finigan J, 
Stubenrauch P, Janssen WJ, Griesmer C, VerBurg O, Hyzy RC, Park PK, Nelson K, 
McSparron JI, Co IN, Wang BR, Jimenez J, Olbrich N, McDonough K, Jia S, Hanna S, 
Gong MN, Richardson LD, Nair R, Lopez B, Amosu O, Offor O, Tzehaie H, Nkemdirim 
W, Boujid S, Mosier JM, Hypes C, Campbell ES, Bixby B, Gilson B, Lopez A, Bime 
C, Parthasarathy S, Cano AM, Hite RD, Terndrup TE, Wiedemann HP, Hudock K, 
Tanzeem H, More H, Martinkovic J, Sellers S, Houston J, Burns M, Kiran S, Roads 
T, Kennedy S, Duggal A, Thiruchelvam N, Ashok K, King AH, Mehkri O, Dugar S, 
Sahoo D, Yealy DM, Angus DC, Weissman AJ, Vita TM, Berryman E, Hough CL, Khan A, 
Krol OF, Mills E, Kinjal M, Briceno G, Reddy R, Hubel K, Jouzestani MK, McDougal 
M, Deshmukh R, Johnston NJ, Robinson BH, Gundel SJ, Katsandres SC, Chen P, 
Torbati SS, Parimon T, Caudill A, Mattison B, Jackman SE, Chen PE, Bayoumi E, 
Ojukwu C, Fine D, Weissberg G, Isip K, Choi-Kuaea Y, Mehdikhani S, Dar TB, 
Fleury Augustin NB, Tran D, Dukov JE, Matusov Y, Choe J, Hindoyan NA, Wynter T, 
Pascual E, Clapham GJ, Herrera L, Caudill A, O'Mahony DS, Nyatsatsang ST, Wilson 
DM, Wallick JA, Duven AM, Fletcher DD, Miller C, Files DC, Gibbs KW, Flores LS, 
LaRose ME, Landreth LD, Palacios DR, Parks L, Hicks M, Goodwin AJ, Kilb EF, 
Lematty CT, Patti K, Grady A, Rasberry A, Morris PE, Sturgill JL, Cassity EP, 
Dhar S, Montgomery-Yates AA, Pasha SN, Mayer KP, Pharm D BB, Trott T, Rehman S, 
de Wit M, Mason J, Bledsoe J, Knowlton KU, Brown S, Lanspa M, Leither L, Pelton 
I, Armbruster BP, Montgomery Q, Kumar N, Fergus M, Imel K, Palmer G, Webb B, 
Klippel C, Jensen H, Duckworth S, Gray A, Burke T, Knox D, Lumpkin J, Aston VT, 
Applegate D, Serezlic E, Brown K, Merril M, Harris ES, Middleton EA, Barrios 
MAG, Greer J, Schmidt AD, Webb MK, Paine R, Callahan SJ, Waddoups LJ, Yamane MB, 
Self WH, Rice TW, Casey JD, Johnson J, Gray C, Hays M, Roth M, Menon V, Kasubhai 
M, Pillai A, Daniel J, Sittler D, Kanna B, Jilani N, Amaro F, Santana J, 
Lyakovestsky A, Madhoun I, Desroches LM, Amadon N, Bahr A, Ezzat I, Guerrero M, 
Padilla J, Fullmer J, Singh I, Ali Shah SH, Narang R, Mock P, Shadle M, 
Hernandez B, Welch K, Payne A, Ertl G, Canario D, Barrientos I, Goss D, DeVries 
M, Folowosele I, Garner D, Gomez M, Price J, Bansal E, Wong J, Faulhaber J, 
Fazili T, Yeary B, Ndolo R, Bryant C, Smigeil B, Robinson P, Najjar R, Jones P, 
Nguyen J, Chin C, Taha H, Najm S, Smith C, Moore J, Nassar T, Gallinger N, 
Christian A, Mauer D, Phipps A, Waters M, Zepeda K, Coslet J, Landazuri R, 
Pineda J, Uribe N, Garcia JR, Barbabosa C, Sandler K, Overcash JS, Marquez A, 
Chu H, Lee K, Quillin K, Garcia A, Lew P, Rogers R, Shehadeh F, Mylona EK, 
Kaczynski M, Tran QL, Benitez G, Mishra B, Felix LO, Vafea MT, Atalla E, Davies 
R, Hedili S, Monkeberg MA, Tabler S, Harrington B, Meegada S, Koripalli VS, 
Muddana P, Jain L, Undavalli C, Kavya P, Ibiwoye M, Akilo H, Lovette BD, Wylie 
JC, Smith DM, Poon K, Eckardt P, Heysu RG, Sundararaman N, Alaby D, Sareli C, 
Sánchez A, Popielski L, Kambo A, Viens K, Turner M, Vjecha MJ, Weintrob A, Brar 
I, Markowitz N, Pastor E, Corpuz R, Alangaden G, McKinnon J, Ramesh M, Herc E, 
Yared N, Lanfranco OA, Rivers E, Swiderek J, Gupta AH, Pabla P, Eliya S, Jazrawi 
J, Delor J, Desai M, Cook A, Jaehne AK, Gill JK, Renaud S, Sarveswaran S, 
Gardner E, Scott J, Bianchini M, Melvin C, Kim G, Wyles D, Kamis K, Miller R, 
Douglas I, Haukoos J, Hicks C, Lazarte S, Marines-Price R, Osuji A, Agbor Agbor 
BT, Petersen T, Kamel D, Hansen L, Garcia A, Cha C, Mozaffari A, Hernandez R, 
Cutrell J, Agbor Agbor BT, Kim M, DellaValle N, Gonzales S, Somboonwit C, Oxner 
A, Guerra L, Hayes M, Nguyen T, Tran T, Pinto A, Hatlen T, Anderson B, 
Zepeda-Gutierrez A, Martin D, Temblador C, Cuenca A, Tanoviceanu R, Prieto M, 
Guerrero M, Martin D, Daar E, Correa R, Hartnell G, Wortmann G, Doshi S, 
Moriarty T, Gonzales M, Garman K, Baker JV, Frosch A, Goldsmith R, Driver B, 
Frank C, Leviton T, Prekker M, Jibrell H, Lo M, Klaphake J, Mackedanz S, Ngo L, 
Garcia-Myers K, Kunisaki KM, Wendt C, Melzer A, Wetherbee E, Drekonja D, Pragman 
A, Hamel A, Thielen A, Kunisaki KM, Hassler M, Walquist M, Augenbraun M, George 
J, Demeo L, Mishko M, Thomas L, Tatem L, Dehovitz J, Abassi M, Leuck AM, Rao V, 
Pullen M, Luke D, LaBar D, Christiansen T, Howard D, Biswas K, Harrington C, 
Garcia A, Bremer T, Burke T, Koker B, Davis-Karim A, Pittman D, Vasudeva SS, 
Johnstone JR, Agnetti K, Davis R, Trautner B, Hines-Munson C, Van J, Dillon L, 
Wang Y, Nagy-Agren S, Vasudeva S, Ochalek T, Caldwell E, Humerickhouse E, Boone 
D, McGraw W, Looney DJ, Mehta SR, Johns ST, St John M, Raceles J, Sear E, Funk 
S, Cesarini R, Fang M, Nicalo K, Drake W, Jones B, Holtman T, Nguyen HH, Maniar 
A, Johnson EA, Nguyen L, Tran MT, Barrett TW, Johnston T, Huggins JT, Beiko TY, 
Hughes HY, McManigle WC, Tanner NT, Washburn RG, Ardelt M, Tuohy PA, Mixson JL, 
Hinton CG, Thornley N, Allen H, Elam S, Boatman B, Baber BJ, Ryant R, Roller B, 
Nguyen C, Mikail AM, Research MH, Lichtenberger P, Baracco G, Ramos C, Bjork L, 
Sueiro M, Tien P, Freasier H, Buck T, Nekach H, Holodniy M, Chary A, Lu K, 
Peters T, Lopez J, Tan SY, Lee RH, Asghar A, Karyn Isip TK, Le K, Nguyen T, Wong 
S, Raben D, Murray DD, Jensen TO, Peters L, Aagaard B, Nielsen CB, Krapp K, 
Nykjær BR, Olsson C, Kanne KL, Grevsen AL, Joensen ZM, Bruun T, Bojesen A, 
Woldbye F, Normand NE, Esman FVL, Benfield T, Clausen CL, Hovmand N, Israelsen 
SB, Iversen K, Leding C, Pedersen KB, Thorlacius-Ussing L, Tinggaard M, 
Tingsgard S, Krohn-Dehli L, Pedersen D, Villadsen S, Staehr Jensen JU, Overgaard 
R, Rastoder E, Heerfordt C, Hedsund C, Ronn CP, Kamstrup PT, Hogsberg DS, 
Bergsoe C, Søborg C, Hissabu NMS, Arp BC, Ostergaard L, Staerke NB, Yehdego Y, 
Sondergaard A, Johansen IS, Pedersen AA, Knudtzen FC, Larsen L, Hertz MA, 
Fabricius T, Holden IK, Lindvig SO, Helleberg M, Gerstoft J, Kirk O, Bruun T, 
Jensen TO, Madsen BL, Pedersen TI, Harboe ZB, Roge BT, Hansen TM, Glesner MK, 
Lofberg SV, Nielsen AD, Leicht von Huth S, Nielsen H, Thisted RK, Petersen KT, 
Juhl MR, Podlekareva D, Johnsen S, Andreassen HF, Pedersen L, Clara Ellinor 
Lindnér CE, Wiese L, Knudsen LS, Skrøder Nytofte NJ, Havmøller SR, Expósito M, 
Badillo J, Martínez A, Abad E, Chamorro A, Figuerola A, Mateu L, España S, 
Lucero MC, Santos JR, Lladós G, Lopez C, Carabias L, Molina-Morant D, Loste C, 
Bracke C, Siles A, Fernández-Cruz E, Di Natale M, Padure S, Gomez J, Ausin C, 
Cervilla E, Balastegui H, Sainz CR, Lopez P, Carbone J, Escobar M, Balerdi L, 
Legarda A, Roldan M, Letona L, Muñoz J, Camprubí D, Arribas JR, Sánchez RM, 
Díaz-Pollán B, Stewart SM, Garcia I, Borobia A, Mora-Rillo M, Estrada V, Cabello 
N, Nuñez-Orantos MJ, Sagastagoitia I, Homen JR, Orviz E, Montalvá AS, 
Espinosa-Pereiro J, Bosch-Nicolau P, Salvador F, Burgos J, Morales-Rull JL, 
Moreno Pena AM, Acosta C, Solé-Felip C, Horcajada JP, Sendra E, Castañeda S, 
López-Montesinos I, Gómez-Junyent J, Gonzáles CG, Cuervo G, Pujol M, Carratalà 
J, Videla S, Günthard H, Braun DL, West E, M'Rabeth-Bensalah K, Eichinger ML, 
Grüttner-Durmaz M, Grube C, Zink V, Pharmacist, Goes Pharmacist J, Fätkenheuer 
G, Malin JJ, Tsertsvadze T, Abutidze A, Chkhartishvili N, Metchurtchlishvili R, 
Endeladze M, Paciorek M, Bursa D, Krogulec D, Pulik P, Ignatowska A, Horban A, 
Bakowska E, Kowaska J, Bednarska A, Jurek N, Skrzat-Klapaczynska A, Bienkowski 
C, Hackiewicz M, Makowiecki M, Platowski A, Fishchuk R, Kobrynska O, Levandovska 
K, Kirieieva I, Kuziuk M, Naucler P, Perlhamre E, Mazouch L, Kelleher A, 
Polizzotto M, Carey C, Chang CC, Hough S, Virachit S, Davidson S, Bice DJ, 
Ognenovska K, Cabrera G, Flynn R, Young BE, Chia PY, Lee TH, Lin RJ, Lye DC, Ong 
SWX, Puah SH, Yeo TW, Diong SH, Ongko J, Yeo HP, Eriobu N, Kwaghe V, Zaiyad H, 
Idoko G, Uche B, Selvamuthu P, Kumarasamy N, Beulah FE, Govindarajan N, 
Mariyappan K, Losso MH, Abela C, Moretto R, Belloc CG, Ludueña J, Amar J, Losso 
MH, Toibaro J, Macias LM, Fernandez L, Frare PS, Chaio SR, Pachioli V, Timpano 
SM, Sanchez MDL, de Paz Sierra M, Stanek V, Belloso W, Cilenti FL, Valentini RN, 
Stryjewski ME, Locatelli N, Soler Riera MC, Salgado C, Baeck IM, Di Castelnuovo 
V, Zarza SM, Hudson F, Parmar MKB, Goodman AL, Dphil, Badrock J, Gregory A, 
Goodall K, Harris N, Wyncoll J, Bhagani S, Rodger A, Luntiel A, Patterson C, 
Morales J, Witele E, Preston AM, Nandani A, Price DA, Hanrath A, Nell J, Patel 
B, Hays C, Jones G, Davidson J, Goodman AL, Bawa T, Mathews M, Mazzella A, 
Bisnauthsing K, Aguilar-Jimenez L, Borchini F, Hammett S, Touloumi G, Pantazis 
N, Gioukari V, Souliou T, Antoniadou A, Protopapas K, Kavatha D, Grigoropoulou 
S, Oikonomopoulo C, Moschopoulos C, Koulouris NG, Tzimopoulos K, Koromilias A, 
Argyraki K, Lourida P, Bakakos P, Kalomenidis I, Vlachakos V, Barmparessou Z, 
Balis E, Zakynthinos S, Sigala I, Gianniou N, Dima E, Magkouta S, Synolaki E, 
Konstanta S, Vlachou M, Stathopoulou P, Panagopoulos P, Petrakis V, Papazoglou 
D, Tompaidou E, Isaakidou E, Poulakou G, Rapti V, Leontis K, Nitsotolis T, 
Athanasiou K, Syrigos K, Argyraki K, Kyriakoulis K, Trontzas I, Arfara-Melanini 
M, Kolonis V, Kityo C, Mugerwa H, Kiweewa F, Kimuli I, Lukaakome J, Nsereko C, 
Lubega G, Kibirige M, Nakahima W, Wangi D, Aguti E, Generous L, Massa R, Nalaki 
M, Magala F, Nabaggala PK, Kidega R, Kityo C, Mugerwa H, Faith OD, Florence A, 
Emmanuel O, Beacham MP, Geoffrey A, Nakiboneka D, Apiyo P, Kiweewa F, Kirenga B, 
Kimuli I, Atukunda A, Muttamba W, Remmy K, Segawa I, Pheona N, Kigere D, Mbabazi 
QL, Boersalino L, Nyakoolo G, Kiweewa F, Fred A, Alupo A, Ebong D, Monday E, 
Nalubwama RN, Kainja M, Ambrose M, Kwehayo V, Nalubega MG, Ongoli A, Obbo S, 
Sebudde N, Alaba J, Magombe G, Tino H, Obonya E, Lutaakome J, Kitonsa J, Onyango 
M, Naboth T, Naluyinda H, Nanyunja R, Irene M, Jane B, Wimfred K, Leonard S, 
Deus T, Babra N, Taire P, Lutaakome J, Nabankema E, Ogavu J, Mugerwa O, Okoth I, 
Mwebaze R, Mugabi T, Makhoba A, Arikiriza P, Theresa N, Nakayima H, Frank K, 
Ramgi P, Pereira K, Osinusi A, Cao H, Klekotka P, Price K, Nirula A, Osei S, 
Tipple C, Wills A, Peppercorn A, Watson H, Gupta R, Alexander E, Mogalian E, Lin 
L, Ding X, Margolis D, Yan L, Girardet JL, Ma J, Hong Z, Zhu Q, Seegobin S, 
Gibbs M, Latchman M, Hasior K, Bouquet J, Wei J, Streicher K, Schmelzer A, 
Brooks D, Butcher J, Tonev D, Arbetter D, Damstetter P, Legenne P, Stumpp M, 
Goncalves S, Ramanathan K, Chandra R, Baseler B, Teitelbaum M, Schechner A, 
Holley HP, Jankelevich S, Adams A, Becker N, Dolney S, Hissey D, Simpson S, Kim 
MH, Beeler J, Harmon L, Asomah M, Jato Y, Stottlemyer A, Tang O, Vanderpuye S, 
Yeon L, Buehn M, Eccard-Koons V, Frary S, MacDonald L, Cash J, Hoopengardner L, 
Linton J, Schaffhauser M, Nelson M, Spinelli-Nadzam M, Proffitt C, Lee C, Engel 
T, Fontaine L, Osborne CK, Hohn M, Galcik M, Thompson D, Kopka S, Shelley DM, 
Mendez G, Brown S, Albert S, Balde A, Baracz M, Bielica M, Billouin-Frazier S, 
Choudary J, Dixon M, Eyler C, Frye L, Gertz J, Giebeig L, Gulati N, Hankinson L, 
Hogarty D, Huber L, Krauss G, Lake E, Manandhar M, Rudzinski E, Sandrus J, 
Suders C, Natarajan V, Rupert AW, Baseler M, Lynam D, Imamichi T, Laverdure S, 
McCormack A, Paudel S, Cook K, Haupt K, Khan A, Hazen A, Badralmaa Y, Smith K, 
Patel B, Kubernac A, Kubernac R, Hoover ML, Solomon C, Rashid M, Murphy J, Brown 
C, DuChateau N, Ellis S, Flosi A, Fox L, Johnson L, Nelson R, Stojanovic J, 
Treagus A, Wenner C, Williams R.

Author information:
(1)Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, 
University of Copenhagen, Copenhagen, Denmark. Electronic address: 
tomas.jensen@regionh.dk.
(2)Division of Biostatistics, University of Minnesota, Minneapolis, MN, USA.
(3)UT Southwestern Medical Center, Dallas, TX, USA.
(4)School of Statistics, University of Minnesota, Minneapolis, MN, USA.
(5)National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA.
(6)Division of Pulmonary and Critical Care Medicine, University of California 
San Francisco, San Francisco, CA, USA.
(7)Division of Infectious Diseases and International Medicine, University of 
Minnesota, Minneapolis, MN, USA.
(8)Division of Infectious Diseases and International Medicine, University of 
Minnesota, Minneapolis, MN, USA; Division of Infectious Diseases, Hennepin 
Healthcare, Minneapolis, MN, USA.
(9)Cedars-Sinai Medical Center, Los Angeles, CA, USA.
(10)Frederick National Laboratory for Cancer Research, Frederick, MD, USA.
(11)The Medical Research Council Clinical Trials Unit, University College 
London, London, UK; Department of Infectious Diseases, Guy's and St Thomas' 
National Health Service Foundation Trust, London, UK.
(12)Lundquist Institute at Harbor-UCLA Medical Center, Torrance, CA, USA.
(13)VA Palo Alto Health Care System, Palo Alto, CA, USA; Department of Medicine, 
Infectious Diseases, Stanford University, Stanford, CA, USA.
(14)Laboratory of Human Retrovirology and Immunoinformatics, Frederick National 
Laboratory for Cancer Research, Frederick, MD, USA.
(15)Emory School of Medicine, Atlanta, GA, USA.
(16)VA San Diego Healthcare Center, San Diego, CA, USA; Division of Infectious 
Diseases and Global Public Health, University of California San Diego, San 
Diego, CA, USA.
(17)National and Kapodistrian University of Athens, School of Medicine, Athens, 
Greece.
(18)Joint Clinical Research Centre, Kampala, Uganda.
(19)Centre of Excellence for Health, Immunity, and Infections, Rigshospitalet, 
University of Copenhagen, Copenhagen, Denmark.
(20)Department of Medicine, Houston Methodist Hospital, Houston, TX, USA; 
Infectious Diseases Division, Brown University, Providence, RI, USA.
(21)Salem Veterans Affairs Medical Center, Salem, VA, USA; Department of 
Internal Medicine, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA.
(22)The Kirby Institute, Sydney, Australia.
(23)Washington DC Veterans Affairs Medical Center, Washington, DC, USA.
(24)Department of Internal Medicine, University of California Davis, Davis, CA, 
USA.
(25)Division of General Internal Medicine, Department of Medicine, Duke 
University School of Medicine, Durham, NC, USA.

BACKGROUND: Serial measurement of virological and immunological biomarkers in 
patients admitted to hospital with COVID-19 can give valuable insight into the 
pathogenic roles of viral replication and immune dysregulation. We aimed to 
characterise biomarker trajectories and their associations with clinical 
outcomes.
METHODS: In this international, prospective cohort study, patients admitted to 
hospital with COVID-19 and enrolled in the Therapeutics for Inpatients with 
COVID-19 platform trial within the Accelerating COVID-19 Therapeutic 
Interventions and Vaccines programme between Aug 5, 2020 and Sept 30, 2021 were 
included. Participants were included from 108 sites in Denmark, Greece, Poland, 
Singapore, Spain, Switzerland, Uganda, the UK, and the USA, and randomised to 
placebo or one of four neutralising monoclonal antibodies: bamlanivimab (Aug 5 
to Oct 13, 2020), sotrovimab (Dec 16, 2020, to March 1, 2021), 
amubarvimab-romlusevimab (Dec 16, 2020, to March 1, 2021), and 
tixagevimab-cilgavimab (Feb 10 to Sept 30, 2021). This trial included an 
analysis of 2149 participants with plasma nucleocapsid antigen, 
anti-nucleocapsid antibody, C-reactive protein (CRP), IL-6, and D-dimer measured 
at baseline and day 1, day 3, and day 5 of enrolment. Day-90 follow-up status 
was available for 1790 participants. Biomarker trajectories were evaluated for 
associations with baseline characteristics, a 7-day pulmonary ordinal outcome, 
90-day mortality, and 90-day rate of sustained recovery.
FINDINGS: The study included 2149 participants. Participant median age was 57 
years (IQR 46-68), 1246 (58·0%) of 2149 participants were male and 903 (42·0%) 
were female; 1792 (83·4%) had at least one comorbidity, and 1764 (82·1%) were 
unvaccinated. Mortality to day 90 was 172 (8·0%) of 2149 and 189 (8·8%) 
participants had sustained recovery. A pattern of less favourable trajectories 
of low anti-nucleocapsid antibody, high plasma nucleocapsid antigen, and high 
inflammatory markers over the first 5 days was observed for high-risk baseline 
clinical characteristics or factors related to SARS-CoV-2 infection. For 
example, participants with chronic kidney disease demonstrated plasma 
nucleocapsid antigen 424% higher (95% CI 319-559), CRP 174% higher (150-202), 
IL-6 173% higher (144-208), D-dimer 149% higher (134-165), and anti-nucleocapsid 
antibody 39% lower (60-18) to day 5 than those without chronic kidney disease. 
Participants in the highest quartile for plasma nucleocapsid antigen, CRP, and 
IL-6 at baseline and day 5 had worse clinical outcomes, including 90-day 
all-cause mortality (plasma nucleocapsid antigen hazard ratio (HR) 4·50 (95% CI 
3·29-6·15), CRP HR 3·37 (2·30-4·94), and IL-6 HR 5·67 (4·12-7·80). This risk 
persisted for plasma nucleocapsid antigen and CRP after adjustment for baseline 
biomarker values and other baseline factors.
INTERPRETATION: Patients admitted to hospital with less favourable 5-day 
biomarker trajectories had worse prognosis, suggesting that persistent viral 
burden might drive inflammation in the pathogenesis of COVID-19, identifying 
patients that might benefit from escalation of antiviral or anti-inflammatory 
treatment.
FUNDING: US National Institutes of Health.

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

DOI: 10.1016/S2666-5247(24)00015-6
PMCID: PMC11181148
PMID: 38815595 [Indexed for MEDLINE]

Conflict of interest statement: Declaration of interests ALG reports receiving 
institutional funding from Novavax, institutional partnership with AstraZeneca, 
and being personally named as inventor on a patent used by AstraZeneca. DDM 
reports receiving grants from the Danish National Research Foundation. DL 
reports participation in a study funded by Gilead with no salary support. EM 
reports payments to his institution received from SciClone Pharmaceuticals, 
Regeneron Pharmaceuticals, Pfizer, Chemic Labs and KODA Therapeutics, and 
Cidara, and payment for participating in an advisory board for Basilea. KW 
reports honorarium for Acute Respiratory Distress Syndrome (ARDS) International 
Conference in 2023, and travel support from University of California San 
Francisco. MAM reports institutional funding by the US Department of Defence, 
Roche-Genetech, and Quantum Health, and personal consulting fees from Gilead, 
Novartis, and Johnson & Johnson. MKJ reports grants received from Regeneron, 
Laurent, and Gilead, honoraria from Gilead, and a leadership role with the HIV 
Medicine Association Board of Directors. PC reports consulting fees from Eli 
Lilly and Regeneron. All other authors declare no competing interests. All 
authors were not precluded from accessing data in the study.